New York A04296 limits off-label use of antipsychotic drugs with black box warnings on elderly dementia patients and classifies non-compliance as.
New York A04296 amends the public health law to restrict the off-label use of antipsychotic drugs with black box warnings on elderly patients with dementia. It prohibits the use of such drugs for purposes other than those approved by the FDA or for chemical restraint. An exception is made for emergency situations where a health care professional specializing in dementia or trained in treating dementia patients deems it necessary to protect the patient's or others' life, health, or safety.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.